Listen "#196 - The Science and Economics of GLP1s"
Episode Synopsis
In one of our most eye-opening conversations yet, Bo Brabo and Luke Carignan sit down with clinical pharmacist Langley Kyle to unpack the truth behind GLP-1 medications—Wegovy, Ozempic, Zepbound, tirzepatide, and their compounded counterparts. Whether you're an HR leader, benefits strategist, or simply trying to understand why GLP-1s dominate workplace conversations, this episode breaks it all down with clarity, expertise, and a surprising amount of laughter.From skyrocketing utilization to social-media-driven demand, Langley reveals what she’s seeing across employer plans nationwide…and what’s coming next.💡 What You’ll Learn in This Episode:1️. Why GLP-1 Coverage Is So Complicated Only 20–30% of self-insured employers currently cover weight-loss GLP-1s. Langley explains why cost, demand, and new FDA indications (sleep apnea, cardiovascular risk reduction, MASH) are forcing employers to rethink their approach.2️. Compounded GLP-1s: Benefits, Risks, and the FDA Crackdown With compounding pharmacies filling the gap during shortages, Langley outlines the regulatory gray zones, quality concerns, and why the FDA is beginning to tighten oversight.3️. The Retention Strategy No One Expected Luke and Bo share firsthand experiences using compounded tirzepatide—and reveal why GLP-1 coverage may soon become a powerful recruitment and retention tool, particularly in healthcare organizations competing for scarce talent.4️. The Real Problem: Maintenance vs. Cure Most members stay on GLP-1s long-term. Langley discusses behavior change, wellness integration, and why employers must pair medication access with coaching, nutrition, and lifestyle programs to create sustainable health outcomes.5️. The Future of Pharmacy Costs From oral GLP-1s to AI-accelerated drug development, the trio explores how innovation—and litigation—may reshape pricing, access, and plan design over the next decade.💬 Quote to Remember: “GLP-1s aren’t going anywhere. The conversation just keeps getting louder.”🎧 Why This Episode Matters GLP-1s are no longer a fringe benefit topic. They are transforming employee expectations, affecting plan costs, and reshaping how HR leaders think about population health. Langley’s insights provide a roadmap for making smarter, more sustainable decisions in 2025 and beyond. From Our Sponsor(s)...Optimize Pharmacy Benefits with RxBenefitsElevate your employee benefits while managing costs. Did you know hospital employees fill 25% more prescriptions annually than other industries? Ensure cost-effective, high-quality pharmacy plans by leveraging your hospital’s own pharmacies. Discover smarter strategies with RxBenefits.Learn More here - https://rxbene.fit/3ZaurZN Support the show
More episodes of the podcast The ASHHRA Podcast
#190 - Veterans Day 2025: How We Serve
11/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.